Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1987-08-17
1989-08-08
Dixon, Jr., William R.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
A61K 4900, G01N 3348
Patent
active
048551260
ABSTRACT:
Processes are provided for the synthesis of the human T-antigenic determinant 2-acetamido-2-deoxy-3-O-(.beta.-D-galactopyranosyl)-.alpha.-D-galactopyran oside containing an .alpha.-O-glycosidically linked bridging arm O--(CH.sub.2).sub.n COR. The determinant is coupled to carrier molecules to form artificial T-antigens, and to insoluble supports to form T-immunoadsorbents. The artificial T-antigen is shown to elicit a delayed type hypersensitivity reaction as a diagnostic for the presence of cancer in humans.
REFERENCES:
patent: 4311688 (1982-01-01), Burchiel
patent: 4351823 (1982-09-01), Rubin
Baker Donald A.
Lemieuz Raymond U.
Ratcliffe Robert M.
Chembiomed Ltd.
Dixon Jr. William R.
Hunter, Jr. James M.
LandOfFree
Method to detect T-antigen delayed hypersensitivity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to detect T-antigen delayed hypersensitivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to detect T-antigen delayed hypersensitivity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-904443